156 related articles for article (PubMed ID: 37944352)
1. Generation of human induced pluripotent stem cell lines derived from four patients with a pathogenic ALPK3 variant associated with adult-onset hypertrophic cardiomyopathy (HCM).
Cheawsamoot C; Ramchandani R; Ameen M; Arthur Ataam J; Khongphatthanayothin A; Shotelersuk V; Karakikes I
Stem Cell Res; 2023 Dec; 73():103233. PubMed ID: 37944352
[TBL] [Abstract][Full Text] [Related]
2. Generation of an induced pluripotent stem cell line (SYSUi005-A) from a patient with hypertrophic cardiomyopathy.
Zhang C; Shi J; Zhang Z; Zhao Q; Xie M; Chen Y; Xiang Q
Stem Cell Res; 2022 Jan; 58():102626. PubMed ID: 34942479
[TBL] [Abstract][Full Text] [Related]
3. Generation of a human iPSC line ZZUNEUi015-A from a patient with hypertrophic cardiomyopathy caused by mutation in ALPK3.
Tian X; Fu W; Guo G; Huang S; Dong Y; Li X; Dong J; Zhao X; Zhang Y
Stem Cell Res; 2021 Apr; 52():102247. PubMed ID: 33607470
[TBL] [Abstract][Full Text] [Related]
4. Generation of induced pluripotent stem cells (iPSCs) from a hypertrophic cardiomyopathy patient with the pathogenic variant p.Val698Ala in beta-myosin heavy chain (MYH7) gene.
Ross SB; Fraser ST; Nowak N; Semsarian C
Stem Cell Res; 2017 Apr; 20():88-90. PubMed ID: 28395747
[TBL] [Abstract][Full Text] [Related]
5. Compound Heterozygosity for Late-Onset Cardiomyopathy-Causative ALPK3 Coding Variant and Novel Intronic Variant Cause Infantile Hypertrophic Cardiomyopathy.
Poleg T; Eskin-Schwartz M; Proskorovski-Ohayon R; Aminov I; Dolgin V; Agam N; Jean M; Safran A; Freund O; Levitas A; Konstantino Y; Birk OS; Westreich R; Haim M
J Cardiovasc Transl Res; 2023 Dec; 16(6):1325-1331. PubMed ID: 37973666
[TBL] [Abstract][Full Text] [Related]
6. Generation of human induced pluripotent stem cell (iPSC) lines derived from five patients carrying the pathogenic phospholamban-R14del (PLN-R14del) variant and three non-carrier family members.
Mittal N; Dave J; Harakalova M; van Tintelen JP; Asselbergs FW; Doevendans PA; Costa KD; Turnbull IC; Stillitano F
Stem Cell Res; 2022 Apr; 60():102737. PubMed ID: 35247838
[TBL] [Abstract][Full Text] [Related]
7. Generation of induced pluripotent stem cell lines from two unrelated individuals with familial hypertrophic cardiomyopathy carrying the MYBPC3 missense c.1484G>A mutation.
Ribeiro M; Martins S; Carvalho T; Furtado M; Sampaio Cabral J; Brito D; Carmo-Fonseca M; da Rocha ST
Stem Cell Res; 2024 Feb; 74():103282. PubMed ID: 38104429
[TBL] [Abstract][Full Text] [Related]
8. An induced pluripotent stem cell line (YCMi006-A) generated from a patient with hypertrophic cardiomyopathy who carries the ACTA1 mutation p.Ile343Met.
Kim H; Kim HJ; Oh J; Lee ST; Won D; Choi HK; Choi JR; Kim S; Kim HP; Kim SJ; Park SW; Kang SM; Lee SH
Stem Cell Res; 2022 Aug; 63():102874. PubMed ID: 35917599
[TBL] [Abstract][Full Text] [Related]
9. Generation of an induced pluripotent stem cell line from a hypertrophic cardiomyopathy patient with a pathogenic myosin binding protein C (MYBPC3) p.Arg502Trp mutation.
Holliday M; Ross SB; Lim S; Semsarian C
Stem Cell Res; 2018 Dec; 33():56-59. PubMed ID: 30316040
[TBL] [Abstract][Full Text] [Related]
10. Generation of an induced pluripotent stem cell line, ICGi029-A, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous p.N515del mutation in MYBPC3.
Dementyeva EV; Pavlova SV; Chernyavsky AM; Zakian SM
Stem Cell Res; 2021 May; 53():102344. PubMed ID: 33892289
[TBL] [Abstract][Full Text] [Related]
11. Development of induced pluripotent stem cells from a patient with hypertrophic cardiomyopathy who carries the pathogenic myosin heavy chain 7 mutation p.Arg403Gln.
Holliday M; Ross SB; Lim S; Mangala M; Hill A; Szappanos HC; Hool L; Semsarian C
Stem Cell Res; 2018 Dec; 33():269-273. PubMed ID: 30508693
[TBL] [Abstract][Full Text] [Related]
12. Generation of human induced pluripotent stem cell lines carrying heterozygous PLN mutation from dilated cardiomyopathy patients.
Caudal A; Mondejar-Parreño G; Vera CD; Williams DR; Shenoy SP; Liang D; Wu JC
Stem Cell Res; 2022 Aug; 63():102855. PubMed ID: 35853412
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood derived induced pluripotent stem cells (iPSCs) from a female with familial hypertrophic cardiomyopathy.
Ross SB; Fraser ST; Bagnall RD; Semsarian C
Stem Cell Res; 2017 Apr; 20():76-79. PubMed ID: 28395744
[TBL] [Abstract][Full Text] [Related]
14. Generation of two heterozygous MYBPC3 mutation-carrying human iPSC lines, SCVIi001-A and SCVIi002-A, for modeling hypertrophic cardiomyopathy.
Liu L; Shenoy SP; Jahng JWS; Liu Y; Knowles JW; Zhuge Y; Wu JC
Stem Cell Res; 2021 May; 53():102279. PubMed ID: 33743363
[TBL] [Abstract][Full Text] [Related]
15. Generation of an induced pluripotent stem cell line, ICGi028-A, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous p.E510Q mutation in HADHA.
Dementyeva EV; Vyatkin YV; Chernyavsky AM; Zakian SM
Stem Cell Res; 2021 May; 53():102348. PubMed ID: 33887580
[TBL] [Abstract][Full Text] [Related]
16. Generation of two clonal iPSC lines, ICGi019-A and ICGi019-B, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous p.M659I mutation in MYH7.
Dementyeva EV; Kovalenko VR; Zhiven MK; Ustyantseva EI; Kretov EI; Vyatkin YV; Zakian SM
Stem Cell Res; 2020 Jul; 46():101840. PubMed ID: 32422568
[TBL] [Abstract][Full Text] [Related]
17. Generation of an induced pluripotent stem cell line (ZJULLi003-A) from a hypertrophic cardiomyopathy patient carrying MYH7/c.4384G > A mutation.
Zhou J; Sun Y; Wang H; Wang H; Guo F; Chen X; Gong T; Jiang C; Liang P
Stem Cell Res; 2022 Oct; 64():102883. PubMed ID: 35944310
[TBL] [Abstract][Full Text] [Related]
18. Expanding the clinical and genetic spectrum of ALPK3 variants: Phenotypes identified in pediatric cardiomyopathy patients and adults with heterozygous variants.
Herkert JC; Verhagen JMA; Yotti R; Haghighi A; Phelan DG; James PA; Brown NJ; Stutterd C; Macciocca I; Leong K; Bulthuis MLC; van Bever Y; van Slegtenhorst MA; Boven LG; Roberts AE; Agarwal R; Seidman J; Lakdawala NK; Fernández-Avilés F; Burke MA; Pierpont ME; Braunlin E; Ḉağlayan AO; Barge-Schaapveld DQCM; Birnie E; van Osch-Gevers L; van Langen IM; Jongbloed JDH; Lockhart PJ; Amor DJ; Seidman CE; van de Laar IMBH
Am Heart J; 2020 Jul; 225():108-119. PubMed ID: 32480058
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and phenotypes associated with ALPK3 null variants in a large French multicentric cohort: Confirming its involvement in hypertrophic cardiomyopathy.
Ader F; Jedraszak G; Janin A; Billon C; Buisson NR; Bloch A; Bensalah M; De Sandre-Giovannoli A; Goudal A; Marsili L; Cazeneuve C; Charron P; Millat G; Richard P;
Clin Genet; 2024 Jun; 105(6):676-682. PubMed ID: 38356193
[TBL] [Abstract][Full Text] [Related]
20. Generation of two iPSC lines from hypertrophic cardiomyopathy patients carrying MYBPC3 and PRKAG2 variants.
Manhas A; Jahng JWS; Vera CD; Shenoy SP; Knowles JW; Wu JC
Stem Cell Res; 2022 May; 61():102774. PubMed ID: 35413566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
